Atrial Fibrillation Trial, Recruiting (NCT05891145)

Atrial Fibrillation Trial, Recruiting NCT05891145 Sponsor: Yangzhou University Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT05891145 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are between 50 and 70 years old
People with a Body Mass Index (BMI) between 18 and 28 (a measure of body weight relative to height)
People who are scheduled to have a planned (non-emergency) coronary artery bypass graft (CABG) heart surgery at the Yangzhou Institute Heart and Great Vessels, the Affiliated Hospital of Yangzhou University, in Yangzhou, China
People who are willing to participate and have signed the required consent form

Who may not be able to join:

People who need emergency surgery
People who are having any other type of heart surgery at the same time
People who have an irregular heart rhythm originating in the upper chambers of the heart (known as supraventricular arrhythmia) before surgery
People who have moderate or severe heart valve disease before surgery
People with a history of chemotherapy or radiation therapy (cancer treatments)
People who have previously had chest (thoracic) or heart and blood vessel (cardiovascular) surgery
People who are taking water pills (diuretics) before surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-13524954567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05891145

Sponsor: Yangzhou University

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: +86-13524954567

More information: https://clinicaltrials.gov/study/NCT05891145

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are between 50 and 70 years old
People with a Body Mass Index (BMI) between 18 and 28 (a measure of body weight relative to height)
People who are scheduled to have a planned (non-emergency) coronary artery bypass graft (CABG) heart surgery at the Yangzhou Institute Heart and Great Vessels, the Affiliated Hospital of Yangzhou University, in Yangzhou, China
People who are willing to participate and have signed the required consent form

Who may not be able to join:

People who need emergency surgery
People who are having any other type of heart surgery at the same time
People who have an irregular heart rhythm originating in the upper chambers of the heart (known as supraventricular arrhythmia) before surgery
People who have moderate or severe heart valve disease before surgery
People with a history of chemotherapy or radiation therapy (cancer treatments)
People who have previously had chest (thoracic) or heart and blood vessel (cardiovascular) surgery
People who are taking water pills (diuretics) before surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Yangzhou University

Registry

ClinicalTrials.gov

Start date

1 February 2023

Est. completion

1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

postoperative Atrial Fibrillation (POAF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov